UniProtKB/SwissProt variant VAR

Variant information

Variant position:

134

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

US

The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Aspartate (D) to Glycine (G) at position 134 (D134G, p.Asp134Gly).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Change from medium size and acidic (D) to glycine (G)

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

-1

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Variant description:

In PLOSL2; unknown pathological significance; decreased protein level.

Any additional useful information about the variant.

Other resources:

Links to websites of interest for the variant.

Variant rs28939079 [ dbSNP | Ensembl ]

Sequence information

Variant position:

134

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

230

The length of the canonical sequence.

Location on the sequence:

HGSEADTLRKVLVEVLADPL D HRDAGDLWFPGESESFEDAH

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         HGSEADTLRKVLVEVLADPLDHRDAGDLWFPGESESFEDAH

Mouse                         RGREAEVLQKVLVEVLEDPLDDQDAGDLWVPEESSSFEGAQ

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	19 – 230	Triggering receptor expressed on myeloid cells 2
Topological domain	19 – 174	Extracellular

Literature citations

Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype.
Paloneva J.; Manninen T.; Christman G.; Hovanes K.; Mandelin J.; Adolfsson R.; Bianchin M.; Bird T.; Miranda R.; Salmaggi A.; Tranebjaerg L.; Konttinen Y.; Peltonen L.;
Am. J. Hum. Genet. 71:656-662(2002)
Cited for: TISSUE SPECIFICITY; INVOLVEMENT IN PLOSL2; VARIANTS PLOSL2 44-TRP--THR-230 DEL; 78-TRP--THR-230 DEL; GLY-134 AND ASN-186;

Neurodegeneration-associated mutant TREM2 proteins abortively cycle between the ER and ER-Golgi intermediate compartment.
Sirkis D.W.; Aparicio R.E.; Schekman R.;
Mol. Biol. Cell 28:2723-2733(2017)
Cited for: SUBCELLULAR LOCATION; CHARACTERIZATION OF VARIANTS CYS-38 AND MET-66; CHARACTERIZATION OF VARIANTS PLOSL2 GLY-126; GLY-134 AND ASN-186;

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q9NZC2: Variant p.Asp134Gly